|

Biogen (BIIB) breakout and retrace signals buying opportunity

Shares of Biogen Inc. (BIIB) are showing signs of life. In 2021, this biotech company traded as high as $470. It currently trades near $140. Biotech and pharma are out of favor these days, but that may be changing.

BIIB recently broke out of a major descending trendline. This trendline goes back to 2023 and has held price below since then. Biogen just broke above it three weeks ago, surging as $160. With a confirmed daily breakout, BIIB has retraced back to the ‘scene of the crime’. 

In technical analysis, this is the buy level investors wait for. In other words, this retrace offers investors a unique opportunity to buy a confirmed breakout, but back at the breakout trendline. While breakouts can fail, probability dictates BIIB should rally higher. The upside target could $190 per technical analysis.

Author

Gareth Soloway

Gareth Soloway

Verified Investing

A renowned trader and financial expert specializing in chart analysis and market insights.

More from Gareth Soloway
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD moves sideways below 1.1800 on Christmas Eve

EUR/USD struggles to find direction and trades in a narrow channel below 1.1800 after posting gains for two consecutive days. Bond and stock markets in the US will open at the usual time and close early on Christmas Eve, allowing the trading action to remain subdued. 

GBP/USD keeps range around 1.3500 amid quiet markets

GBP/USD keeps its range trade intact at around 1.3500 on Wednesday. The Pound Sterling holds the upper hand over the US Dollar amid pre-Christmas light trading as traders move to the sidelines heading into the holiday season. 

Gold retreats from record highs, trades below $4,500

Gold retreats after setting a new record-high above $4,520 earlier in the day and trades in a tight range below $4,500 as trading volumes thin out ahead of the Christmas break. The US Dollar selling bias remains unabated on the back of dovish Fed expectations, which continues to act as a tailwind for the bullion amid persistent geopolitical risks.

Bitcoin slips below $87,000 as ETF outflows intensify, whale participation declines

Bitcoin price continues to trade around $86,770 on Wednesday, after failing to break above the $90,000 resistance. US-listed spot ETFs record an outflow of $188.64 million on Tuesday, marking the fourth consecutive day of withdrawals.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Avalanche struggles near $12 as Grayscale files updated form for ETF

Avalanche trades close to $12 by press time on Wednesday, extending the nearly 2% drop from the previous day. Grayscale filed an updated form to convert its Avalanche-focused Trust into an ETF with the US Securities and Exchange Commission.